论文部分内容阅读
为了解药物经βCD包合后的生物体内性质建立了HPLCUV法以测定酮洛芬在家兔体内的血药浓度。用酵母诱导家兔的发热反应,考察酮洛芬βCD包合物与其单体的药代动力学—药效动力学(PKPD)。结果表明:建立的HPLCUV法简便可行;酮洛芬βCD包合物在分布相T1/2α为04h,而其单体的T1/2α为056h,反映了包合后酮洛芬吸收更快;在效应—浓度—时间曲线上,包合后的酮洛芬早期效应略高;酮洛芬给药后的效应峰值滞后于血药浓度峰值,提示药物的效应室在外周室
HPLC-UV method was developed to determine the concentration of ketoprofen in rabbits to understand the biological properties of the drug after inclusion by β-CD. Yeast-induced fever in rabbits with ketoprofen βCD inclusion complex and its monomer pharmacokinetics - pharmacodynamics (PK PD). The results showed that the HPLC-UV method was simple and feasible. The inclusion phase of ketoprofen βCD in the distribution phase T1 / 2α was 04h and the monomer T1 / 2α was 056h, Ketoprofen absorption faster; in the effect - concentration - time curve, the inclusion of ketoprofen early effect slightly higher; peak effect of ketoprofen after administration lags behind the peak plasma concentration, suggesting that the drug’s effect in the room Peripheral room